In this stage, the tumor-inhibiting effect of CD8+ CTLs is suppressed by FOXP3+ Tregs, myeloid suppressor cells (MDSCs), neutrophils, M2 macrophages, Th2 CD4+ T cells and cytokines such as TGF-β, IL-6. This evidence concerns the gene CD8A and neoplasm.